A systematic review of infliximab in the treatment of early rheumatoid arthritis
Sophie Martin Du Pan, Cem Gabay, Axel FinckhDivision of Rheumatology, Department of Internal Medicine, University of GenevaBackground: Several health authorities have recently revised the indication of infliximab (IFX) to include the treatment of early rheumatoid arthritis (RA).The aim of this systematic review of the literature was to appraise the